iRhythm price target raised to $104 from $86 at Wells Fargo

Wells Fargo analyst Nathan Treybeck raised the firm’s price target on iRhythm (IRTC) to $104 from $86 and keeps an Equal Weight rating on the shares. The firm notes iRhythm reported a Q4 revenue beat above what it expected, driven to a large extent by a competitor disruption and rapid uptake from a new partner. Both may not be durable and iRhythm’s 2025 guidance assumes this, Wells adds.